- Home
- SPRY vs OCFC Comparison
SPRY vs OCFC Comparison
Compare SPRY & OCFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- OCFC
- Stock Information
- Founded
- SPRY 2015
- OCFC 1902
- Country
- SPRY United States
- OCFC United States
- Employees
- SPRY N/A
- OCFC N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- OCFC Major Banks
- Sector
- SPRY Health Care
- OCFC Finance
- Exchange
- SPRY Nasdaq
- OCFC Nasdaq
- Market Cap
- SPRY 1.1B
- OCFC 1.1B
- IPO Year
- SPRY N/A
- OCFC 1996
- Fundamental
- Price
- SPRY $12.57
- OCFC $18.76
- Analyst Decision
- SPRY Strong Buy
- OCFC Hold
- Analyst Count
- SPRY 4
- OCFC 4
- Target Price
- SPRY $26.00
- OCFC $21.00
- AVG Volume (30 Days)
- SPRY 1.5M
- OCFC 322.8K
- Earning Date
- SPRY 11-13-2024
- OCFC 01-23-2025
- Dividend Yield
- SPRY N/A
- OCFC 4.26%
- EPS Growth
- SPRY N/A
- OCFC N/A
- EPS
- SPRY N/A
- OCFC 1.74
- Revenue
- SPRY $2,568,000.00
- OCFC $380,971,000.00
- Revenue This Year
- SPRY $66,750.00
- OCFC N/A
- Revenue Next Year
- SPRY $508.63
- OCFC $5.39
- P/E Ratio
- SPRY N/A
- OCFC $10.77
- Revenue Growth
- SPRY 8460.00
- OCFC N/A
- 52 Week Low
- SPRY $6.00
- OCFC $14.03
- 52 Week High
- SPRY $18.51
- OCFC $21.87
- Technical
- Relative Strength Index (RSI)
- SPRY 58.86
- OCFC 53.25
- Support Level
- SPRY $11.00
- OCFC $18.41
- Resistance Level
- SPRY $12.48
- OCFC $19.30
- Average True Range (ATR)
- SPRY 0.81
- OCFC 0.49
- MACD
- SPRY 0.28
- OCFC 0.16
- Stochastic Oscillator
- SPRY 84.95
- OCFC 73.00
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management services.